RECIST criteria are inadequate for measuring ... For this reason, The Prostate Cancer Clinical Trials Working Group has defined radiological progression as the development of two or more lesions ...
It’s tough for a man to know what to do following a diagnosis of prostate cancer.The treatment is often worse than the ...
A new study by UC San Francisco found that prostate cancer cases are increasing in California, likely due to a change in ...
The RECIST-evaluable patients included patients ... have been implicated as important in castration-resistant prostate cancer. Synergistic anti-tumor activity has been reported with the sequential ...
Advanced prostate cancer cases are rising sharply in California, outpacing national trends, according to a new study from ...
The deal sees Endocyte acquire an exclusive worldwide licence for ABX’s phase 3-ready prostate cancer candidate 177Lu ... in 40% to 60% of patients, and a RECIST response rate in soft tissue ...
Israeli pharmaceutical company RedHill Biopharma has initiated a placebo-controlled Phase II trial to assess the combination ...
Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback